Acrivon Therapeutics CEO Peter Blume-Jensen's 2023 pay falls 70% to $6.5M
Acrivon Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 26, 2024
Acrivon Therapeutics reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, three executives at Acrivon Therapeutics received on average a compensation package of $2.6M, a 69% decrease compared to previous year.
Average pay of disclosed executives at Acrivon Therapeutics
Peter Blume-Jensen, Chief Executive Officer, received $6.5M in total, which decreased by 70% compared to 2022. 85% of Blume-Jensen's compensation, or $5.5M, was in stock awards. Blume-Jensen also received $349K in non-equity incentive plan and $629K in salary.
Kristina Masson, Executive Vice President, Business Operations, Director, received a compensation package of $740K. 70% of the compensation package, or $521K, was in salary.
Mary-Alice Miller, Chief Legal Officer, earned $697K in 2023.
Related executives
You may also like
Source: SEC filing on April 26, 2024.